Literature DB >> 11812166

Melatonin protection against lethal myocyte injury induced by doxorubicin as reflected by effects on mitochondrial membrane potential.

Meifeng Xu1, Muhammad Ashraf.   

Abstract

Melatonin (MLT) is highly protective against cardiotoxicity caused by doxorubicin (DOX). DOX induces cardiac damage via production of reactive oxygen species. This study tests the hypothesis that oxygen radicals generated by DOX disrupt mitochondrial membrane potential (Delta(psi)(m)) prior to severe cell injury. Myocytes were incubated with 20 micromol/l DOX for 24 h. Myocyte damage was estimated by lactate dehydrogenase (LDH) release. Mitochondrial membrane potential was determined by staining myocytes with 5, 5', 6, 6'-tetrachloro-1, 1', 3, 3'-tetraethylbenzimidazolcarbocyanine iodide (JC-1) using confocal microscope. A significant amount of LDH was observed after 24 h of treatment with DOX. Mitochondria in DOX-treated myocytes exhibited a collapse of Delta(psi)(m). Pretreatment with melatonin (1 mmol/l) for one hour prevented the release of LDH and restored Delta(psi)(m). The data support the hypothesis that DOX induces damage to mitochondria through radicals, and this is reflected in depolarization of Delta(psi)(m), which was prevented by melatonin. Copyright 2002 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11812166     DOI: 10.1006/jmcc.2001.1485

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  7 in total

1.  Baicalein protects against doxorubicin-induced cardiotoxicity by attenuation of mitochondrial oxidant injury and JNK activation.

Authors:  Wei-Tien Chang; Jing Li; Hsien-Hao Haung; Huiping Liu; Mei Han; Srinivasan Ramachandran; Chang-Qing Li; Willard W Sharp; Kimm J Hamann; Chun-Su Yuan; Terry L Vanden Hoek; Zuo-Hui Shao
Journal:  J Cell Biochem       Date:  2011-10       Impact factor: 4.429

Review 2.  Antioxidative protection by melatonin: multiplicity of mechanisms from radical detoxification to radical avoidance.

Authors:  Rüdiger Hardeland
Journal:  Endocrine       Date:  2005-07       Impact factor: 3.633

Review 3.  Poly(ADP-ribose) polymerase-2: emerging transcriptional roles of a DNA-repair protein.

Authors:  Magdolna Szántó; Attila Brunyánszki; Borbála Kiss; Lilla Nagy; Pál Gergely; László Virág; Péter Bai
Journal:  Cell Mol Life Sci       Date:  2012-05-13       Impact factor: 9.261

4.  Melatonin, a potent agent in antioxidative defense: actions as a natural food constituent, gastrointestinal factor, drug and prodrug.

Authors:  Rüdiger Hardeland; S R Pandi-Perumal
Journal:  Nutr Metab (Lond)       Date:  2005-09-10       Impact factor: 4.169

5.  Melatonin in Alzheimer's disease and other neurodegenerative disorders.

Authors:  V Srinivasan; S R Pandi-Perumal; D P Cardinali; B Poeggeler; R Hardeland
Journal:  Behav Brain Funct       Date:  2006-05-04       Impact factor: 3.759

Review 6.  Evidence for the Benefits of Melatonin in Cardiovascular Disease.

Authors:  Mohammad Tobeiha; Ameneh Jafari; Sara Fadaei; Seyed Mohammad Ali Mirazimi; Fatemeh Dashti; Atefeh Amiri; Haroon Khan; Zatollah Asemi; Russel J Reiter; Michael R Hamblin; Hamed Mirzaei
Journal:  Front Cardiovasc Med       Date:  2022-06-20

Review 7.  Oncostatic-Cytoprotective Effect of Melatonin and Other Bioactive Molecules: A Common Target in Mitochondrial Respiration.

Authors:  Nicola Pacini; Fabio Borziani
Journal:  Int J Mol Sci       Date:  2016-03-07       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.